406 results on '"Graner, Michael"'
Search Results
2. Higher Levels of IgG3 Antibodies in Serum, But Not in CSF, Distinguish Multiple Sclerosis From Other Neurological Disorders
3. Multiple sclerosis plasma IgG aggregates induce complement-dependent neuronal apoptosis
4. Possible regulation of the immune modulator tetraspanin CD81 by alpha-synuclein in melanoma
5. Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis
6. Targeting DNA Methyl Transferases with Decitabine in Cultured Meningiomas
7. Rapid Activation of Neuroinflammation in Stroke: Plasma and Extracellular Vesicles Obtained on a Mobile Stroke Unit
8. A tale of two tumors: differential, but detrimental, effects of glioblastoma extracellular vesicles (EVs) on normal human brain cells
9. Specific Binding of Alzheimer’s Aβ Peptides to Extracellular Vesicles
10. Abstract 106: Circulating Interleukin-6 Levels Early During Active Stroke Estimate Time of Stroke Onset: Potential New Clinical Biomarker Tool From a Mobile Stroke Unit
11. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands
12. Varicella-Zoster Virus infected human neurons are resistant to apoptosis
13. The Potential of Exosomes From Cow Milk for Oral Delivery
14. Possible regulation of the immune modulator tetraspanin CD81 by alpha-synuclein in melanoma
15. Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype
16. Immunopathology of Extracellular Vesicles in Macrophage and Glioma Cross-Talk
17. Extracellular vesicles in cancer immune responses: roles of purinergic receptors
18. Tumor-derived exosomes, microRNAs, and cancer immune suppression
19. Abstract 1357: Alpha-synuclein may promote melanoma progression by modulating the levels of tetraspanin proteins
20. Abstract 17: Ultra-early Activation Of Neuroinflammatory Cascade Following Acute Stroke: Plasma And Extracellular Vesicle Biomarkers From A Mobile Stroke Unit
21. Extracellular Vesicles as Vehicles of B Cell Antigen Presentation
22. List of Contributors
23. High-Throughput Screening of Epigenetic Inhibitors in Meningiomas Identifies HDAC, G9a, and Jumonji-Domain Inhibition as Potential Therapies.
24. Conference report for the 2nd annual American Society for Intercellular Communication (ASIC) meeting, 2022
25. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes
26. Phenotype and Neuronal Cytotoxic Function of Glioblastoma Extracellular Vesicles
27. Neutrophil transfer of miR-223 to lung epithelial cells dampens acute lung injury in mice
28. The Role of Heat Shock Proteins in the Elicitation of Immune Responses
29. Glioblastoma Extracellular Vesicle-Specific Peptides Inhibit EV-Induced Neuronal Cytotoxicity
30. High-Throughput Screening of Epigenetic Inhibitors in Meningiomas Identifies HDAC, G9a, and Jumonji-Domain Inhibition as Potential Therapies
31. Abstract 1575: Knocking out alpha synuclein causes decreased release of extracellular vesicles in melanoma cells
32. Chaperone Proteins/Heat Shock Proteins As Anticancer Vaccines
33. Editorial: Blood-Based Biomarkers in Acute Ischemic Stroke and Hemorrhagic Stroke
34. DNA Methyl Transferase Inhibition in Meningiomas
35. High-Throughput Screening of FDA-Approved Compounds, Validated with Three Separate Xenograft Models, Identifies Brigatinib as a Potential Treatment for Recurrent and Metastatic Chordomas
36. High-Throughput Screening of Meningiomas Identifies Proteasome Inhibition as a Potential Treatment Avenue
37. HSP90 and Immune Modulation in Cancer
38. Engagement of Toll-like Receptor 2 on CD4⁺ T Cells Facilitates Local Immune Responses in Patients with Tuberculous Pleurisy
39. A report on ASIC2021: a conference on extracellular vesicle communication mechanisms
40. DDRE-43. SCREENING OF FDA-APPROVED COMPOUNDS FOR THE TREATMENT OF CHORDOMA, WITH IN VIVO VALIDATION USING THREE DIFFERENT XENOGRAFT MODELS, IDENTIFIES BRIGATINIB AS A POTENTIAL TREATMENT
41. DDRE-10. SCREENING OF EPIGENETIC COMPOUNDS IN GLIOMA AND GLIOBLASTOMA IDENTIFIES NOVEL THERAPEUTICS FOR THEIR POTENTIAL TREATMENT
42. DDRE-45. HIGH-THROUGHPUT SCREENING OF EPIGENETIC COMPOUNDS FOR THE TREATMENT OF CHORDOMA IDENTIFIES POTENTIAL NOVEL THERAPEUTICS
43. DDRE-20. HIGH-THROUGHPUT SCREENING OF FDA-APPROVED COMPOUNDS IN GLIOMA AND GLIOBLASTOMA IDENTIFIES NOVEL THERAPEUTICS
44. Chapter Eight: HSP90 and Immune Modulation in Cancer
45. Immunology and Immunotherapy in Brain Tumors — Immune Failure and Potential Counteractions
46. Immune Modulation by Tumor-Derived Extracellular Vesicles in Glioblastoma
47. Clinical Trials in Glioblastoma — Designs and Challenges
48. Binding of Monomeric and Polymeric Alzheimer’s Aβ peptides to Exosomes
49. Exosomes Secreted Under Hypoxia Enhance Invasiveness and Stemness of Prostate Cancer Cells by Targeting Adherens Junction Molecules
50. Revision Workshops: An Alternative to Peer Editing Groups
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.